• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

髓鞘少突胶质细胞糖蛋白抗体交联后激活的信号级联反应:对多发性硬化症的潜在影响。

Signaling cascades activated upon antibody cross-linking of myelin oligodendrocyte glycoprotein: potential implications for multiple sclerosis.

作者信息

Marta Cecilia B, Montano Michael B, Taylor Christopher M, Taylor Ava L, Bansal Rashmi, Pfeiffer Steven E

机构信息

Department of Neuroscience, University of Connecticut Medical School, Farmington, Connecticut 06030-3401, USA.

出版信息

J Biol Chem. 2005 Mar 11;280(10):8985-93. doi: 10.1074/jbc.M413174200. Epub 2005 Jan 4.

DOI:10.1074/jbc.M413174200
PMID:15634682
Abstract

Antibody-induced demyelination is an important component of pathology in multiple sclerosis. In particular, antibodies to myelin oligodendrocyte glycoprotein (MOG) are elevated in multiple sclerosis patients, and they have been implicated as mediators of demyelination. We have shown previously that antibody cross-linking of MOG in oligodendrocytes results in the repartitioning of MOG into glycosphingolipid-cholesterol membrane microdomains ("lipid rafts"), followed by changes in the phosphorylation of specific proteins, including dephosphorylation of beta-tubulin and the beta subunit of the trimeric G protein and culminating in rapid and dramatic morphological alterations. In order to further elucidate the mechanism of anti-MOG-mediated demyelination, we have carried out a proteomic analysis to identify the set of proteins for which the phosphorylation states or expression levels are altered upon anti-MOG treatment. We demonstrate that treatment of oligodendrocytes with anti-MOG alone leads to an increase in calcium influx and activation of the MAPK/Akt pathways that is independent of MOG repartitioning. However, further cross-linking of anti-MOG.MOG complexes with a secondary anti-IgG results in the lipid raft-dependent phosphorylation of specific proteins related to cellular stress response and cytoskeletal stability. Oligodendrocyte survival is not compromised by these treatments. We discuss the possible significance of the anti-MOG-induced signaling cascade in relation to the initial steps of MOG-mediated demyelination.

摘要

抗体诱导的脱髓鞘是多发性硬化症病理学的一个重要组成部分。特别是,髓鞘少突胶质细胞糖蛋白(MOG)抗体在多发性硬化症患者中升高,并且它们被认为是脱髓鞘的介质。我们之前已经表明,少突胶质细胞中MOG的抗体交联导致MOG重新分配到糖鞘脂 - 胆固醇膜微区(“脂筏”)中,随后特定蛋白质的磷酸化发生变化,包括β-微管蛋白和三聚体G蛋白的β亚基去磷酸化,并最终导致快速而显著的形态学改变。为了进一步阐明抗MOG介导的脱髓鞘机制,我们进行了蛋白质组学分析,以鉴定抗MOG处理后磷酸化状态或表达水平发生改变的蛋白质组。我们证明,单独用抗MOG处理少突胶质细胞会导致钙内流增加和MAPK/Akt途径激活,这与MOG重新分配无关。然而,用二级抗IgG进一步交联抗MOG.MOG复合物会导致与细胞应激反应和细胞骨架稳定性相关的特定蛋白质的脂筏依赖性磷酸化。这些处理不会损害少突胶质细胞的存活。我们讨论了抗MOG诱导的信号级联反应与MOG介导的脱髓鞘初始步骤相关的可能意义。

相似文献

1
Signaling cascades activated upon antibody cross-linking of myelin oligodendrocyte glycoprotein: potential implications for multiple sclerosis.髓鞘少突胶质细胞糖蛋白抗体交联后激活的信号级联反应:对多发性硬化症的潜在影响。
J Biol Chem. 2005 Mar 11;280(10):8985-93. doi: 10.1074/jbc.M413174200. Epub 2005 Jan 4.
2
Antibody cross-linking of myelin oligodendrocyte glycoprotein leads to its rapid repartitioning into detergent-insoluble fractions, and altered protein phosphorylation and cell morphology.髓鞘少突胶质细胞糖蛋白的抗体交联导致其迅速重新分配到去污剂不溶性组分中,并改变蛋白质磷酸化和细胞形态。
J Neurosci. 2003 Jul 2;23(13):5461-71. doi: 10.1523/JNEUROSCI.23-13-05461.2003.
3
Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology.致病性髓鞘少突胶质细胞糖蛋白抗体识别糖基化表位并扰乱少突胶质细胞生理学。
Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):13992-7. doi: 10.1073/pnas.0504979102. Epub 2005 Sep 19.
4
Antibodies directed against rubella virus induce demyelination in aggregating rat brain cell cultures.针对风疹病毒的抗体在聚集的大鼠脑细胞培养物中诱导脱髓鞘。
J Neurosci Res. 2001 Sep 1;65(5):446-54. doi: 10.1002/jnr.1173.
5
Microglial Fc receptors mediate physiological changes resulting from antibody cross-linking of myelin oligodendrocyte glycoprotein.小胶质细胞Fc受体介导由髓鞘少突胶质细胞糖蛋白抗体交联引起的生理变化。
J Neuroimmunol. 2008 May 30;196(1-2):35-40. doi: 10.1016/j.jneuroim.2008.02.002. Epub 2008 Apr 11.
6
The remyelinating potential and in vitro differentiation of MOG-expressing oligodendrocyte precursors isolated from the adult rat CNS.从成年大鼠中枢神经系统分离出的表达髓鞘少突胶质细胞糖蛋白(MOG)的少突胶质前体细胞的髓鞘再生潜力及体外分化
Eur J Neurosci. 2004 Sep;20(6):1445-60. doi: 10.1111/j.1460-9568.2004.03606.x.
7
A chimeric receptor of the insulin-like growth factor receptor type 1 (IGFR1) and a single chain antibody specific to myelin oligodendrocyte glycoprotein activates the IGF1R signalling cascade in CG4 oligodendrocyte progenitors.一种1型胰岛素样生长因子受体(IGFR1)的嵌合受体和一种对髓鞘少突胶质细胞糖蛋白具有特异性的单链抗体可激活CG4少突胶质前体细胞中的IGF1R信号级联反应。
Biochim Biophys Acta. 2011 Aug;1813(8):1428-37. doi: 10.1016/j.bbamcr.2011.04.006. Epub 2011 May 4.
8
The myelin oligodendrocyte glycoprotein (MOG): a model for antibody-mediated demyelination in experimental autoimmune encephalomyelitis and multiple sclerosis.髓鞘少突胶质细胞糖蛋白(MOG):实验性自身免疫性脑脊髓炎和多发性硬化中抗体介导的脱髓鞘模型。
J Neural Transm Suppl. 2000(58):123-33. doi: 10.1007/978-3-7091-6284-2_10.
9
Epitope specificity of demyelinating monoclonal autoantibodies directed against the human myelin oligodendrocyte glycoprotein (MOG).针对人髓鞘少突胶质细胞糖蛋白(MOG)的脱髓鞘单克隆自身抗体的表位特异性
J Neuroimmunol. 1999 Jun 1;97(1-2):9-15. doi: 10.1016/s0165-5728(99)00010-7.
10
Demyelination induced in aggregating brain cell cultures by a monoclonal antibody against myelin/oligodendrocyte glycoprotein.一种针对髓鞘/少突胶质细胞糖蛋白的单克隆抗体在聚集脑细胞培养物中诱导的脱髓鞘作用。
J Neurochem. 1990 Aug;55(2):583-7. doi: 10.1111/j.1471-4159.1990.tb04173.x.

引用本文的文献

1
Paediatric Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Case Report With Varied Clinical Manifestations.儿童髓鞘少突胶质细胞糖蛋白抗体相关疾病(MOGAD):一例临床表现多样的病例报告
Cureus. 2025 Jun 1;17(6):e85173. doi: 10.7759/cureus.85173. eCollection 2025 Jun.
2
Should We Consider Neurodegeneration by Itself or in a Triangulation with Neuroinflammation and Demyelination? The Example of Multiple Sclerosis and Beyond.我们应该单独考虑神经退行性变,还是将其与神经炎症和脱髓鞘联系起来综合考量?以多发性硬化症及其他疾病为例。
Int J Mol Sci. 2024 Nov 25;25(23):12637. doi: 10.3390/ijms252312637.
3
Pathophysiology of myelin oligodendrocyte glycoprotein antibody disease.
髓鞘少突胶质细胞糖蛋白抗体病的病理生理学
Front Neurol. 2023 Feb 28;14:1137998. doi: 10.3389/fneur.2023.1137998. eCollection 2023.
4
Coexistence of Myelin Oligodendrocyte Glycoprotein Immunoglobulin G and Neuronal or Glial Antibodies in the Central Nervous System: A Systematic Review.中枢神经系统中髓鞘少突胶质细胞糖蛋白免疫球蛋白G与神经元或神经胶质抗体的共存:一项系统综述
Brain Sci. 2022 Jul 27;12(8):995. doi: 10.3390/brainsci12080995.
5
Clinical and Prognostic Analysis of Autoantibody-Associated CNS Demyelinating Disorders in Children in Southwest China.中国西南地区儿童自身抗体相关中枢神经系统脱髓鞘疾病的临床及预后分析
Front Neurol. 2021 Mar 26;12:642664. doi: 10.3389/fneur.2021.642664. eCollection 2021.
6
The NF-κB/leukemia inhibitory factor/STAT3 signaling pathway in antibody-mediated suppression of Sindbis virus replication in neurons.抗体介导的抑制辛德比斯病毒在神经元中复制的 NF-κB/白血病抑制因子/STAT3 信号通路。
Proc Natl Acad Sci U S A. 2020 Nov 17;117(46):29035-29045. doi: 10.1073/pnas.2016691117. Epub 2020 Nov 3.
7
Myelin-Associated MAL and PLP Are Unusual among Multipass Transmembrane Proteins in Preferring Ordered Membrane Domains.髓鞘相关的MAL和PLP在多跨膜蛋白中与众不同,它们更倾向于有序膜结构域。
J Phys Chem B. 2020 Jul 16;124(28):5930-5939. doi: 10.1021/acs.jpcb.0c03028. Epub 2020 Jun 4.
8
The role of B cells in multiple sclerosis: Current and future therapies.B 细胞在多发性硬化症中的作用:当前和未来的治疗方法。
Cell Immunol. 2019 May;339:10-23. doi: 10.1016/j.cellimm.2018.10.006. Epub 2018 Oct 21.
9
Myelin oligodendrocyte glycoprotein antibodies in neurological disease.髓鞘少突胶质细胞糖蛋白抗体与神经系统疾病
Nat Rev Neurol. 2019 Feb;15(2):89-102. doi: 10.1038/s41582-018-0112-x.
10
KIR2DL4-HLAG interaction at human NK cell-oligodendrocyte interfaces regulates IFN-γ-mediated effects.人类 NK 细胞-少突胶质细胞界面上的 KIR2DL4-HLAG 相互作用调节 IFN-γ 介导的作用。
Mol Immunol. 2019 Nov;115:39-55. doi: 10.1016/j.molimm.2018.09.027. Epub 2018 Nov 24.